IDE397
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IDE397, covering 2026-04-09 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors [Phase 1, Phase 2]